Lifeway Foods, Inc. (LWAY) SEC Filings & Earnings Calls
EquiReason read 18 Lifeway Foods, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-13 — Q2 2026 net sales grew 24.1% YoY but gross margin contracted sharply to 19.5% from 28.6%, net income fell to $0.1M from $4.2M..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 339.3M
- P/E TTM
- 32.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
13 Aug 202610-QQ2 2026 net sales grew 24.1% YoY but gross margin contracted sharply to 19.5% from 28.6%, net income fell to $0.1M from $4.2M.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $67M | +24% y/y |
| Gross profit margin · Q2-2026 | 19.5% | |
| Net income · Q2-2026 | $127000.00 | -97% y/y |
| Selling expenses as % of net sales · Q2-2026 | 11.4% | |
| Drinkable Kefir net sales · Q2-2026 | $59M | +27% y/y |
| Capital expenditures · H1-2026 | $20M | +331% y/y |
| Line of credit outstanding · 2026-06-30 | $22M | |
| Advertising expense · Q2-2026 | $5M | +110% y/y |
Risks flagged
Input cost inflation
“The decrease versus the prior year was driven by the unfavorable impact of milk pricing and to a lesser extent the unfavorable impact of resin-based packaging inputs and transportation costs.” · word for word
Customer concentration
“Two major customers accounted for a total of 25% of net sales for the six months ended June 30, 2026 and 2025.” · word for word
13 Aug 20268-K · 2.02Lifeway Foods reports record Q2 2026 net sales of $66.9M (+24.1% YoY), 27th consecutive quarter of growth; gross margin pressured by elevated milk costs.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $67M | +24% y/y |
| Gross profit margin · Q2-2026 | 19.5% | |
| Net income · Q2-2026 | $100000.00 | |
| Diluted net income per share · Q2-2026 | $0.01 | |
| Net sales (first half) · H1-2026 | $130M | +30% y/y |
| Gross profit margin (first half) · H1-2026 | 23.4% | |
| Net income (first half) · H1-2026 | $5M | |
| Diluted net income per share (first half) · H1-2026 | $0.31 |
Risks flagged
Elevated milk prices causing significant gross margin compression (19.5% vs 28.6%)
“Gross Profit Margin: 19.5%, compared to 28.6% in the prior-year period, primarily reflecting elevated milk prices” · word for word
Temporary increases in resin and transportation costs adding to margin pressure
“temporary increases in resin costs for packaging and higher oil-related transportation costs” · word for word
7 Jul 20268-K · 1.01, 2.03Entered Master Security Agreement providing up to $22M equipment financing facility with SOFR+1.65% interest, convertible to 5-year term note.open
Figures in the filing · each found in the filing text
| Equipment financing facility · FY2027 | $22M | |
| Interest rate spread · Q3-2026 | 1.6% |
Risks flagged
Secured debt increases financial obligations
“Master Security Agreement and Equipment Guidance Line Note create secured obligations”
20 May 2026SC 13D/ADanone S.A. and its subsidiary sold their entire stake in Lifeway Foods, Inc., ceasing to be reporting persons.open
Risks flagged
Major shareholder exit
“Danone S.A. and Danone USA Public Benefit Corporation no longer beneficially own any securities of the Issuer and therefore shall cease to be reporting persons.”
20 May 2026SC 13D/ASmolyansky family insider group discloses 24.5% beneficial ownership in Lifeway Foods, Inc., with no change in intent or control.open
Figures in the filing · each found in the filing text
| Outstanding shares · 2026-05-19 | 15,025,478 |
20 May 2026SC 13D/ASmolyansky family insider group discloses 24.5% beneficial ownership in Lifeway Foods, Inc., with no change in intent or control.open
Figures in the filing · each found in the filing text
| Outstanding shares · 2026-05-19 | 15,025,478 |
20 May 2026SC 13D/ADanone S.A. and its subsidiary sold their entire stake in Lifeway Foods, Inc., ceasing to be reporting persons.open
Risks flagged
Major shareholder exit
“Danone S.A. and Danone USA Public Benefit Corporation no longer beneficially own any securities of the Issuer and therefore shall cease to be reporting persons.”
14 May 20268-K · 2.02Record Q1 net sales $63.0M (+36.7% YoY), gross margin expanded 360bps to 27.5%, net income $4.7M (+32% YoY). Reiterated FY2027 Adj. EBITDA target of $45-50M.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $63M | +37% y/y |
| Gross Profit Margin · Q1-2026 | 27.5% | |
| Net Income · Q1-2026 | $5M | +34% y/y |
| SG&A Expenses · Q1-2026 | $11M | +17% y/y |
Guidance
FY2027 Adjusted EBITDA target of $45-50 million; FY2026 expected to be strongest annual sales in company history
Reiterated long-term EBITDA target and expressed confidence in record FY2026 sales.
Risks flagged
Dependence on consumer health trends and GLP-1 drug user demand; any reversal could impact sales.
“demand from GLP-1 users seeking nutrient-dense, probiotic foods is particularly strong” · word for word
14 May 202610-QLifeway Foods reported strong Q1 2026 results with 36.7% revenue growth, significant margin expansion, and positive operating cash flow.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $63M | +37% y/y |
| Net income · Q1-2026 | $5M | +32% y/y |
| Operating cash flow · Q1-2026 | $4M | +3019% y/y |
Risks flagged
Customer concentration risk
“Two major customers accounted for a total of 26% and 24% of net sales for the three months ended March 31, 2026 and 2025, respectively.” · word for word
Capital expenditure risk
“The project will be funded primarily through cash on-hand and cash flow from operations, with further requirements available under the Company’s revolving credit facility.” · word for word
30 Apr 2026DEF 14AProxy statement for 2026 annual meeting; includes say-on-pay vote, board refreshment via Cooperation Agreement with Danone, and compensation details.open
Figures in the filing · each found in the filing text
| Net Revenue · FY2025 | $213M | +14% y/y |
| Adjusted EBITDA · FY2025 | $33M | +15% y/y |
| Net Income · FY2025 | $14M | +54% y/y |
1 Apr 20268-K · 2.02Lifeway Foods projects Q1 2026 net sales $60.8-62.3M, +32-35% YoY, driven by kefir and farmer cheese demand.open
Guidance
Q1 2026 net sales $60.8-62.3M vs prior year $46.1M
Strong preliminary Q1 2026 outlook with 32-35% YoY growth.
Risks flagged
Preliminary estimates subject to adjustment; commodity price risk.
“Preliminary financial outlook; forward-looking statements caution.”
17 Mar 202610-KLifeway reported strong annual results with revenue up 13.7% and net income up 84.6%.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $212M | +14% y/y |
| Drinkable Kefir Revenue · Drinkable Kefir · FY2025 | $181M | +18% y/y |
| Net Income · FY2025 | $57M | +85% y/y |
Risks flagged
Customer Concentration
“Two customers accounted for a total of 24% of our total net sales.” · word for word
Milk Price Volatility
“Conventional milk prices were lower in fiscal 2025 than the prior year, and there can be no assurance that such prices will remain at these levels in the future.” · word for word
Shareholder Activism / Control
“Our five largest shareholders... beneficially owned approximately 18%, 20%, 6%, 23% and 9% of the Company’s outstanding common stock, respectively, as of December 31, 2025.”
17 Mar 20268-K · 2.02Lifeway Foods reports record FY2025 net sales of $212.5M (+13.7% YoY), gross margin expansion of 140 bps to 27.4%, net income growth of 54% to $13.9M, and reiterates FY2027 Adjusted EBITDA target of $45-50M.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $213M | +14% y/y |
| Gross Profit Margin · FY2025 | 27.4% | |
| Net Income · FY2025 | $14M | +54% y/y |
| Q4 Net Sales · Q4-2025 | $55M | +18% y/y |
| Q4 Gross Profit Margin · Q4-2025 | 27.8% | |
| Q4 Net Income · Q4-2025 | $3M | -1350% y/y |
Guidance
FY2027 Adjusted EBITDA target of $45-50 million reiterated; FY2026 expected to deliver strongest annual sales in company history.
Company reiterates long-term EBITDA target and expresses confidence in continued growth, supported by strong 2025 results and favorable consumer trends.
Risks flagged
Dependence on consumer discretionary spending and health trends; potential for input cost inflation.
“Company operates in competitive food industry; no specific risks highlighted beyond standard forward-looking statements.”
8 Jan 20268-K · 2.02Lifeway Foods expects record net sales of $211-212.5M for FY2025, indicating strong growth and record-breaking revenue.open
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $212M |
Guidance
FY2025 net sales expected $211-212.5M
Company expects record net sales for FY2025, indicating strong demand and growth.
Risks flagged
Guidance is preliminary and subject to risks including competition, commodity pricing, and regulatory changes.
“Forward-looking statements caution that actual results may differ materially due to various risks.”
12 Nov 20258-K · 2.02, 7.01Record Q3 net sales of $57.1M (+24% YoY), 300bps gross margin expansion to 28.7%, net income $3.5M (+19% YoY). Reiterated FY2027 Adj. EBITDA target of $45-50M. Strong volume-led growth and operational execution.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $57M | +24% y/y |
| Gross Profit Margin · Q3-2025 | 28.7% | |
| Net Income · Q3-2025 | $4M | +17% y/y |
| Earnings Per Share (Basic) · Q3-2025 | $0.23 | +15% y/y |
| Selling Expense as % of Net Sales · Q3-2025 | 8.8% |
Guidance
FY2027 Adjusted EBITDA target $45-50M
Reiterated long-term target of $45-50M Adjusted EBITDA for FY2027; on pace for strongest annual sales in FY2025.
Risks flagged
Dependence on consumer trends (GLP-1, gut health) may shift; commodity price volatility could impact margins.
“price competition; the decisions of customers or consumers; changes in the pricing of commodities”
12 Nov 202510-QLifeway Foods reported Q3 2025 net sales of $57.1M (+24% YoY) and net income of $3.5M (+19% YoY), with gross margin expanding 300bps.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $57M | +24% y/y |
| Net Income · Q3-2025 | $4M | +19% y/y |
| Gross Profit · Q3-2025 | $16M | +38% y/y |
| Gross Margin · Q3-2025 | 28.7% | |
| Operating Cash Flow · 9M-2025 | $11M | -31% y/y |
| Capital Expenditures · 9M-2025 | $10M | +78% y/y |
| Cash and Cash Equivalents · 2025-09-30 | $23M | |
| Drinkable Kefir Revenue · Drinkable Kefir · Q3-2025 | $50M | +31% y/y |
| Advertising Expense · Q3-2025 | $3M | +59% y/y |
Risks flagged
Unsolicited acquisition proposal distraction
“The Company incurred approximately $2,400 of professional fees associated with the Danone unsolicited purchase proposal and non-routine stockholder action.” · word for word
Organic milk supply cost pressure
“The increase versus the prior year was driven by higher volumes of our branded products, which provided manufacturing efficiencies and the favorable impact of conventional milk pricing, partially offset by organic milk pricing and planned trade promotion investment.” · word for word
Lifeway Foods, Inc. — questions
- What did Lifeway Foods, Inc. file recently?
- 18 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-13 — Q2 2026 net sales grew 24.1% YoY but gross margin contracted sharply to 19.5% from 28.6%, net income fell to $0.1M from $4.2M.
Every figure on this page comes from Lifeway Foods, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.